About The Founder  

Dr. Taneisha McFarlane, the founder and CEO of HistoCare Bioscience, is an accomplished oncology researcher with extensive clinical and research experience in cellular pathology and materials engineering. Given her firsthand exposure to challenges such as the use of toxic chemicals in healthcare laboratories and the limited availability of diverse analyte controls (formalin-fixed paraffin-embedded tissues), she understands the frustrations faced by biomedical scientists, clinicians, and researchers.

A passionate advocate, she founded HistoCare to improve sustainability and to enhance the efficiency, accuracy of histopathology diagnosis.

She leads initiatives to integrate environmentally responsible practices into healthcare and scientific research by utilising the LEAF (Laboratory Efficiency Assessment Framework) structured actions.

Dr. McFarlane is committed to reducing the use of toxic chemicals and has spearheaded efforts to replace these harmful substances with environmentally friendly alternatives and set new standards for responsible innovation in the healthcare industry.